GCP Inspection is carried out to improve the quality of clinical trials, and to strengthen the safety and protection of the rights of clinical trial subjects. Recently, On-site GCP inspection has become difficult due to COVID-19 prolongation. This phenomenon has increased the need for remote/virtual GCP Inspections to strengthen the information protection and the clinical trial management. In this paper, current status of global remote/virtual GCP Inspections is investigated through several emergency guidelines, recently issued by foreign regulatory agencies such as the US FDA, European EMA, and Japanese PMDA. Considerations for domestic introduction derived from these guidelines are like: (1) Records assessment of US FDA (2) Feasibility Assessment of the European EMA (3) overall procedure of Japan PMDA guideline. From a legal point of view, the domestic personal information protection law is similar to the GDPR of Europe, and it means that conducting rSDV for medical institutions is difficult. Therefore, obtaining consent for the use of personal information from clinical trial subjects and finding rSDV method considering security are essential to conduct remote/virtual inspections. Remote/virtual GCP Inspections guidelines, which are in harmony with global regulatory trends, can be used as standards for examining high-quality clinical trials, regulatory guidelines for drug development and management, and springboard for document management of RWD.
목차
Abstract 서론 본론 1. 연구방법 2. 연구결과 고찰 및 결론 1. 실태조사 관리 및 조정의 책임 2. 국내 의료법 및 개인정보 보호법에 대한 임상시험대상자 관련 정보보호 주의사항과 rSDV에 대한 고려사항 3. 기대효과 감사의 말씀 References
키워드
remote/virtual GCP inspectionsforeign regulatory agenciesremote source data verification; rSDV
한국보건사회약료경영학회 [Korean Academy of Social & Managed Care Phemacy]
설립연도
2009
분야
의약학>약학
소개
본 학회는 비영리 학술단체로서 환자의 삶의 질 향상을 위한 약료(pharmaceutical care)가 보장될 수 있도록 약료경영약학(managed care pharmacy)을 발전시키는 데 궁극 목적을 두고 다음과 같은 활동을 전개하여 사회에 기여하며 회원 상호간의 친목을 도모한다.
간행물
간행물명
한국보건사회약료경영학회지 [Journal of Korean Academy of Managed Care Pharmacy]